MedTrace Logo

Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome

NCT00000572 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-03-06

No results posted yet for this study

Summary

To compare conventional therapy using low frequency positive pressure ventilation with extracorporeal CO2 removal for the treatment of adult respiratory distress syndrome (ARDS).

Conditions

  • Acute Respiratory Distress Syndrome
  • Lung Diseases

Interventions

PROCEDURE

positive-pressure ventilation

Detailed computer protocol controlled positive pressure ventilation

PROCEDURE

extracorporeal membrane oxygenation (CO2 removal)

Detailed computer protocol controlled Extracorporeal CO2 Removal with reduced positive pressure ventilation

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Intermountain Health Care, Inc.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1987-06-30
Primary Completion
1991-04-30
Completion
1993-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000572 on ClinicalTrials.gov